| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/27/2011 | CA2372553C Attenuated microorganisms for the treatment of infection |
| 09/27/2011 | CA2351015C Novel system for regulating transgene expression |
| 09/27/2011 | CA2336218C Neurotrophic factors |
| 09/22/2011 | WO2011116371A2 Polyplex gene delivery vectors |
| 09/22/2011 | WO2011116351A2 Methods and compositions for the treatment of cancer |
| 09/22/2011 | WO2011115810A2 Isoform-specific rnai based on codon redundancy/degeneracy |
| 09/22/2011 | WO2011115555A1 System for improved delivery of gene modulating compounds |
| 09/22/2011 | WO2011115271A1 Tumor angiogenesis inhibitor |
| 09/22/2011 | WO2011113889A1 Modified u7 snrnas for treatment of neuromuscular diseases |
| 09/22/2011 | US20110230548 Multicistronic vectors and methods for their design |
| 09/22/2011 | US20110230544 Modulation of c-reactive protein expression |
| 09/22/2011 | US20110230422 Purging of an ex vivo hematopoietic stem cell culture of cancer cells |
| 09/22/2011 | US20110230407 Hepatocyte growth factor pathway activators in demyelinating diseases and central nervous system trauma |
| 09/22/2011 | US20110229579 Support Having Nanostructured Titanium Dioxide Film And Uses Thereof |
| 09/22/2011 | US20110229528 Pegylated polyplexes for polynucleotide delivery |
| 09/22/2011 | US20110229515 Identification of genes |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229478 Erbb3 based methods and compositions for treating neoplasms |
| 09/22/2011 | US20110229473 Methods for using taci-immunoglobulin fusion proteins |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229434 Uses of mammalian cytokine; related reagents |
| 09/22/2011 | CA2793663A1 Polyplex gene delivery vectors |
| 09/22/2011 | CA2793521A1 Methods and compositions for the treatment of cancer |
| 09/22/2011 | CA2792696A1 Modified u7 snrnas for treatment of neuromuscular diseases |
| 09/21/2011 | EP2366774A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366773A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366772A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366771A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366712A2 A tumor suppressor designated TS10Q23.3 |
| 09/21/2011 | EP2366706A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 09/21/2011 | EP2365962A2 Aminoalcohol lipidoids and uses thereof |
| 09/21/2011 | EP1879624B1 Gene therapy for neurometabolic disorders |
| 09/21/2011 | EP1573009B1 Detection of small nucleic acids |
| 09/21/2011 | EP1519956B1 Epha2 monoclonal antibodies and methods of use thereof |
| 09/21/2011 | EP1471926B8 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 09/21/2011 | EP1385993B8 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 09/21/2011 | EP1296998B1 Hcv variants |
| 09/21/2011 | EP1274464B1 Compositions and methods for regulated protein expression in gut |
| 09/21/2011 | EP1068357B1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 09/21/2011 | EP0725791B1 Recombinant p53 adenovirus methods and compositions |
| 09/21/2011 | CN1952129B Angptl4 deletion mutant and application thereof |
| 09/21/2011 | CN1894278B Akt activity specifically inhibiting polypeptide |
| 09/21/2011 | CN1468089B Microparticles for delivery of the heterologous nucleic acids |
| 09/21/2011 | CN102191310A Application of miRNA (micro Ribonucleic Acid) related to sensitivity to camptothecin medicaments |
| 09/21/2011 | CN102191272A Antifertility recombinant plasmid and genetic vaccine and preparation method and applications thereof |
| 09/21/2011 | CN102191271A Anti-tumor recombinant plasmid as well as gene vaccine, preparation method and application thereof |
| 09/21/2011 | CN102191246A Multi-target interfering nucleic acid molecule and application thereof |
| 09/21/2011 | CN102191244A Group of siRNA molecules capable of effectively reducing PRDM1beta expression and application thereof |
| 09/21/2011 | CN102191233A Novel 10-23 deoxyribozyme analogue and application thereof |
| 09/21/2011 | CN102191224A Heavy targeted modification method for herpes simplex viruses and application thereof |
| 09/21/2011 | CN102191209A VEGF165 and Ang-1 double-gene co-expression vector and application thereof |
| 09/21/2011 | CN102188719A Application of EB virus miR-BART3 antisense oligonucleotides in preparing medicament for treating nasopharyngeal darcinoma |
| 09/21/2011 | CN102188718A Application of micromolecule RNA has-miR-29c in preparing medicine treating liver cancer |
| 09/21/2011 | CN102188707A Application of IL-17 inhibitor in preparing medicament for treating influenza |
| 09/21/2011 | CN101538556B Method for replicating adenovirus by way of selection and mutual compensation |
| 09/21/2011 | CN101254171B Spray containing small molecule disturbance ribonucleic acid |
| 09/20/2011 | US8022195 Expression vector comprising nucleotide sequences coding UP50 protein and endothelial growth factor for use in treatment of vascular disorders; regenerative medicine; tissue engineering and repair |
| 09/20/2011 | US8022189 Isolated antibodies against biologically active leptin-related peptides |
| 09/20/2011 | US8022174 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 09/20/2011 | US8022044 Compositions and methods for therapeutic use |
| 09/20/2011 | US8021866 Therapeutic use of ADPase enhanced apyrases |
| 09/20/2011 | US8021838 Transcriptional regulation of target genes |
| 09/20/2011 | US8021832 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021686 Serum and/or intercellular degradation and clearance prevention; delivering antisense nucleic acids and/or ribozymes; high drug to lipid ratios |
| 09/20/2011 | US8021662 Microorganisms for therapy |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2476477C Tissue specific expression |
| 09/20/2011 | CA2426348C Retrovirus isolated from humans |
| 09/20/2011 | CA2426334C Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2369848C Human endogenous retrovirus in breast cancer |
| 09/20/2011 | CA2347248C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 09/20/2011 | CA2319700C Methods of identifying genes involved in enhanced wound healing in mice |
| 09/20/2011 | CA2262403C Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| 09/20/2011 | CA2259144C Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |
| 09/15/2011 | WO2011113050A1 Method and composition for alveolar epithelial cell-specific nucleic acid nuclear import |
| 09/15/2011 | WO2011113030A2 Human cancer micro-rna expression profiles predictive of chemo-response |
| 09/15/2011 | WO2011112983A2 Psrp is a protective antigen against pneumococcal infection |
| 09/15/2011 | WO2011112902A2 Nonviral gene delivery vector iopamidol, protamine, ethiodized oil reagent (viper) |
| 09/15/2011 | WO2011112669A1 Non-aqueous high concentration reduced viscosity suspension formulations |
| 09/15/2011 | WO2011112607A2 NKX3-1 saRNA AND KLF4 saRNA AND USES THEREOF |
| 09/15/2011 | WO2011111824A1 Method for proliferating cardiomyocytes using micro-rna |
| 09/15/2011 | WO2011111715A1 Nucleic acid capable of regulating cell cycle |
| 09/15/2011 | WO2011111051A1 Death associated protein 1 variants and use thereof for modulating autophagy |
| 09/15/2011 | WO2010048275A3 Lyophilized recombinant vwf formulations |
| 09/15/2011 | US20110224415 Human muty |
| 09/15/2011 | US20110224287 Augmented cognitive training |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224282 iRNA Agents Targeting VEGF |
| 09/15/2011 | US20110224277 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224146 Augmented cognitive training |
| 09/15/2011 | US20110224144 Compositions and methods for diagnosing and treating mental disorders |
| 09/15/2011 | US20110223180 Methods and compositions related to a multi-methylation assay to predict patient outcome |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | CA2792517A1 Non-aqueous high concentration reduced viscosity suspension formulations |